Aurinia Pharmaceuticals
AUPH
#4822
Rank
S$2.57 B
Marketcap
S$19.23
Share price
-1.59%
Change (1 day)
-4.64%
Change (1 year)

EPS for Aurinia Pharmaceuticals (AUPH)

EPS in 2026 (TTM): S$3.07

According to Aurinia Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S$3.09. In 2025 the company made an earnings per share (EPS) of S$2.80 an increase over its 2024 EPS that were of S$0.06457.

EPS history for Aurinia Pharmaceuticals from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$3.079.55%
2025S$2.804240%
2024S$0.06457
2022S-$0.98-46.1%
2021S-$1.8263.95%
2020S-$1.11-33.85%
2019S-$1.6873.33%
2018S-$0.97-34.78%
2017S-$1.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Regeneron Pharmaceuticals
REGN
S$60.67 1,865.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
S-$22.73-836.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
S-$2.65-185.73%๐Ÿ‡บ๐Ÿ‡ธ USA